| Catalog Number | 10868-1-AP |
| Synonyms | ATP1A3, ATP1A3 (middle), Alpha(III), ATP1A 3, DYT12 |
| Host | Rabbit |
| Reactivity | human, mouse, rat |
| Form | Liquid |
| Formulation | PBS, Azide, Glycerol |
| Applications | WB, IHC, IF-P, ELISA |
| Host / Isotype | Rabbit / IgG |
| Tested Applications — Positive WB detected in | C2C12 cell, C2C12 cells, mouse brain tissue |
| Tested Applications — Positive IHC detected in | human prostate cancer tissue, mouse brain tissue, mouse skeletal muscle tissue, human cerebellum tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Tested Applications — Positive IF-P detected in | mouse brain tissue |
| Recommended Dilutions — Western Blot (WB) | WB : 1:500-1:3000 |
| Recommended Dilutions — Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Recommended Dilutions — Immunofluorescence (IF)-P | IF-P : 1:50-1:500 |
| Positive WB detected in | C2C12 cell, C2C12 cells, mouse brain tissue |
| Positive IHC detected in | human prostate cancer tissue, mouse brain tissue, mouse skeletal muscle tissue, human cerebellum tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF-P detected in | mouse brain tissue |
| Western Blot (WB) | WB : 1:500-1:3000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)-P | IF-P : 1:50-1:500 |
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse, rat |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen | CatNo: Ag1313 Product name: Recombinant human ATP1A3 protein Source: e coli. -derived, PGEX-4T Tag: GST Domain: 665-1013 aa of BC015566 Sequence: SEQIDEILQNHTEIVFARTSPQQKLIIVEGCQRQGAIVAVTGDGVNDSPALKKADIGVAMGIAGSDVSKQAADMILLDDNFASIVTGVEEGRLIFDNLKKSIAYTLTSNIPEITPFLLFIMANIPLPLGTITILCIDLGTDMVPAISLAYEAAESDIMKRQPRNPRTDKLVNERLISMAYGQIGMIQALGGFFSYFVILAENGFLPGNLVGIRLNWDDRTVNDLEDSYGQQWTYEQRKVVEFTCHTAFFVSIVVVQWADLIICKTRRNSVFQQGMKNKILIFGLFEETALAAFLSYCPGMDVALRMYPLKPSWWFCAFPYSFLIFVYDEIRKLILRRNPGGWVEKETYY Predict reactive species |
| Full Name | ATPase, Na+/K+ transporting, alpha 3 polypeptide |
| Calculated Molecular Weight | 113 kDa |
| Observed Molecular Weight | 100-113 kDa |
| GenBank Accession Number | BC015566 |
| Gene Symbol | ATP1A3 |
| Gene ID (NCBI) | 478 |
| RRID | AB_2060962 |
| Conjugate | Unconjugated |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P13637 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA. |
| IF protocol for ATP1A3 (C-terminal) antibody 10868-1-AP | Download protocol |
| IHC protocol for ATP1A3 (C-terminal) antibody 10868-1-AP | Download protocol |
| WB protocol for ATP1A3 (C-terminal) antibody 10868-1-AP | Download protocol |
| human | IHC Cancer Cell Int Comprehensive analysis of the expression of sodium/potassium-ATPase α subunits and prognosis of ovarian serous cystadenocarcinoma. Authors - Wei Huang View Article |
| mouse | WB Acta Neuropathol Commun Bridging the gap: investigating the role of phosphorylation at the serine 129 site of α-synuclein in VAPB-PTPIP51 interactions Authors - Weijin Liu View Article |
| Citations | 9 |
| Dilutions | WB : 1:500-1:3000 IHC : 1:50-1:500 IF-P : 1:50-1:500 |
| Isotype | IgG |
| Clonality | Polyclonal |
| Clone Number | - |
| Conjugation | Unconjugated |
ATP1A3 participates in the catalyticing hydrolysis of ATP and the exchanging of sodium and potassium ions across plasma membrane. The catalyticing activity mode is ATP + H2O + Na + (In) + K + (Out) = ADP + phosphate + Na + (Out) + K + (In). It has been published that the neurologic disorders rapid-onset dystonia-parkionsonism (RDP), alternating hemiplegia of childhood (ACH) and CAPOS syndrome (cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorineural hearing loss) are all related with the mutation of ATP1A3. There are other reports suggest that early life epilepsy and episodic apnea revealing are potentially associated with the mutation of ATP1A3 as a result of impairment of Na + /K + homeostasis. This antibody is generated against the C-terminal region (665-1013aa) of ATP1A3 and detects the band around 100-113 kDa in SDS-PAGE.(PMID: 30097153, 20301294, 29922587) Protocols Product Specific Protocols IF protocol for ATP1A3 (C-terminal) antibody 10868-1-AP Download protocol IHC protocol for ATP1A3 (C-terminal) antibody 10868-1-AP Download protocol WB protocol for ATP1A3 (C-terminal) antibody 10868-1-AP Download protocol Standard Protocols Click here to view our Standard Protocols
Publications